Tudor Investment Corp
FBIO icon

Tudor Investment Corp’s Fortress Biotech FBIO Stock Holding History

Tudor Investment Corp’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-753
Closed -$30K – 1257
2013
Q4 		$30K Buy
+753
New +$29.1K ﹤0.01% 1242

Other funds holding FBIO

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
Advent Capital Management New York $4.46B AUM 0.73% 1-Year Est. Return

Tudor Investment Corp's FBIO Position: Q1 2014 in Review

Tudor Investment Corp sold out of Fortress Biotech (FBIO) in Q1 2014, closing a stake of 753 shares — an estimated $30K sold.

Tudor Investment Corp first reported a position in FBIO in Q4 2013 and held it in 1 quarter. The position peaked at $30K in Q4 2013. 57 funds tracked by Wall St. Rank hold FBIO as of Q1 2014.

  • Tudor Investment Corp reported no remaining Fortress Biotech position as of Q1 2014 after selling out during the quarter.
  • Tudor Investment Corp sold 753 Fortress Biotech shares in Q1 2014, an estimated $30K.
  • Tudor Investment Corp first reported a position in Fortress Biotech in Q4 2013 and held it in 1 quarter.
  • Tudor Investment Corp's Fortress Biotech position peaked at $30K in Q4 2013.
  • 57 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2014.

Based on Tudor Investment Corp's 13F filing for Q1 2014, filed 15 May 2014.